跳至主要内容
临床试验/JPRN-UMIN000018970
JPRN-UMIN000018970已完成未知

An observational study to investigate patient-reported satisfaction with apixaban when switched from warfarin in Japanese NVAF patients (AGAIN study) - Patient-reported satisfaction in Japanese NVAF patients (AGAIN Study)

Pfizer Japan Inc.0 个研究点目标入组 865 人开始时间: 2015年9月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
865

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients whose warfarin is switched to apixaban at the timing of invasive procedures other than catheter ablation for treatment of AF. 2.Patients with a history of hypersensitivity to the active substance (apixaban) or to any of the excipients of this drug 3.Patients with clinically significant active bleeding. (judged by a physician in charge of the patients) 4.Patients with hepatic disease associated with coagulopathy and clinically relevant bleeding risk. (judged by a physician in charge of the patients) 5.Patients with renal failure (creatinine clearance <15 mL/min) (No clinical experience) 6.Patients who are not able to answer to the questionnaires.

研究者

相似试验

An observational study to investigate... | 临床试验